Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank

Affiliations

• ¹ WCG-ACI Clinical, 3 Bala Cynwyd, PA 19004. Electronic address: jseltzer@aciclinical.com.
• ² Division of Hematology Products, Office of Drug Evaluation 1, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Electronic address: Ann.Farrell@fda.hhs.gov.
• ³ Divisions of Hematology, Johns Hopkins School of Medicine, Baltimore, MD, Johns Hopkins Pediatric Thrombosis Program, St. Petersburg, FL, - Baltimore, MD, All Children's Research Institute. Electronic address: neil@jhmi.edu.
• ⁴ Duke University, Duke Clinical Research Institute. Electronic address: christoph.hornik@duke.edu.
• ⁵ Office of Clinical Trials/ Bureau des Essais Clinique, Centre for Regulatory Excellence, Statistics and Trials/Centre d'Excellence Réglementaire, de Statistiques et Essais Clinique, Ottawa, Ontario, Canada. Electronic address: daniel.keene@canada.ca.
• ⁶ Duke University Medical Center. Electronic address: mitchell.krucoff@duke.edu.
• ⁷ Janssen Research and Development LLC, Rahway, NJ. Electronic address: clipardi@its.jnj.com.
• ⁸ Department of Pediatrics, University of Alberta. Electronic address: Patti.Massicotte@albertahealthservices.ca.
• ⁹ Paul-Ehrlich-Institut. Electronic address: Dirk.Mentzer@pei.de.
• ¹⁰ The University of Melbourne Academic Centre, Royal Children's Hospital, The University of Melbourne. Electronic address: Paul.Monagle@rch.org.au.
• ¹¹ UC San Diego, Hemophilia and Thrombosis Treatment Center, Rady Children's Hospital San Diego. Electronic address: cthornburg@rchsd.org.
• ¹² Global Clinical Lead, Apixaban, Pfizer Inc., Global Product Development, CVMET Therapeutic Area, Groton, CT. Electronic address: James.H.Revkin@pfizer.com.
• ¹³ Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Electronic address: shetarra.walker@fda.hhs.gov.
• ¹⁴ Intercontinental Regulatory Strategy Lead, Bristol-Myers Squibb. Electronic address: diptee.gajjar@bms.com.